Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension
Journal of Psychopharmacology 2022 DOI: 10.1177/02698811211058933 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 211,549 |
| Population | US general population respondents to the National Survey on Drug Use and Health (2015–2019) |
| Topics | Mescaline Psilocybin |
| Keywords | Recidivism Odds ratio Antisocial personality disorder Population Prison Poison control Injury prevention Criminology Demography |
| Citations | 30 |
| Key findings | Lifetime psilocybin use was associated with lowered odds of past year arrests for seven of eleven crime categories, while peyote and mescaline were associated with reduced odds of specific offenses. |
Abstract
Background: The United States boasts the largest prison population in the world, conferring significant direct and indirect costs (e.g. lost wages for the incarcerated, increased morbidity/mortality, etc.) to society. Recidivism rates are high for the imprisoned and most interventions to reduce criminality are minimally effective. Thus, in addition to the need for criminal justice reform, there is a need to better understand factors linked to lowered criminal behavior.
Aim: The aim of this study was to assess the relationships between the use of classic psychedelic substances (psilocybin, LSD, peyote, and mescaline) and past year arrests for various crimes (i.e. property, violence, alcohol and substance use, miscellaneous crimes).
Methods: This study used nationally representative data from The National Survey on Drug Use and Health (NSDUH) (2015–2019) ( N = 211,549) to test the aforementioned associations.
Results: Lifetime psilocybin use was associated with lowered odds of seven of 11 past year arrest variables (adjusted odds ratio (aOR) range = 0.30–0.73). Peyote was associated with reduced odds of motor vehicle theft (aOR = 0.30) and driving under the influence (aOR = 0.52), and mescaline was associated with reduced odds of drug possession/sale (aOR = 0.51). Virtually all other substances either shared no relationship to our outcomes or conferred higher odds of arrest.
Conclusion: This study suggests that use of classic psychedelic substances is associated with lowered odds of crime arrests. Future research should explore whether causal factors and/or third variable factors (e.g. personality, political orientation) underlie the relationship between classic psychedelic use and reduced criminal behavior.
Comparable studies
Other cross-sectional and survey studies on psilocybin, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences Individuals who had consumed psilocybin mushrooms and experienced a psychologically... | 2016 | Cross-sectional survey | n = 1,993 |
| The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms Internet survey respondents reporting challenging experiences with psilocybin | 2016 | Questionnaire development and validation | |
| Psychedelics and Mental Health: A Population Study Adult population in the United States | 2013 | Cross-sectional survey | n = 130,152 |
| Cessation and reduction in alcohol consumption and misuse after psychedelic use Individuals with prior alcohol use disorder who reported cessation or reduction in... | 2019 | Cross-sectional survey | n = 343 |
| Patterns of simultaneous polysubstance use in drug using university students Drug-using university students | 2006 | Cross-sectional survey | n = 149 |
Citations in the library
Cited by 28
- Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample Scientific Reports April 7, 2022
- Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study Scientific Reports February 16, 2022
- Psychedelics in the treatment of unipolar and bipolar depression International Journal of Bipolar Disorders July 5, 2022
- Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes Journal of Psychopharmacology October 31, 2022
- Acid liberalism: Silicon Valley's enlightened technocrats, and the legalization of psychedelics. International Journal of Drug Policy December 1, 2022
and 23 more in the library
Cites 35
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
and 30 more in the library